DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

Mylan Inc. (NASDAQ: MYL)

69.64 -0.30 (-0.43%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MYL $69.64 -0.43%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $70.00
Previous Close $69.94
Daily Range $69.49 - $70.55
52-Week Range $44.80 - $76.69
Market Cap $34.1B
P/E Ratio 32.08
Dividend (Yield) $0.00 (0.0%)
Volume 4,328,406
Average Daily Volume 9,835,869
Current FY EPS $4.13

Sector

Healthcare

Industry

Drug Makers

Mylan Inc. (MYL) Description

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients. Website: http://www.mylan.com/

News & Commentary Rss Feed

Billionaire George Soros Just Sold These 3 Stocks: Should You?

The Soros Fund Management sold Kite Pharma, Valeant Pharmaceuticals, and Teva Pharmaceutical Industries Ltd. in the first quarter. Should you follow in its footsteps?

Will Competition Cause Teva Pharmaceutical Industries ltd. To Tumble?

The FDA has approved Novartis' biosimilar to Teva Pharmaceuticals' Copaxone.

Endo International Acquires Par Pharmaceuticals For $8 Billion

TARO: Yes, We Have A Winner

Huge Tech Stock Added to UBS Quality Growth at a Reasonable Price Portfolio

Tom Russo Buys 3 New Stocks in Q1

Theravance Biopharma: The Potential Of TD-4208

Perrigo (PRGO) Buys Patheon's Mexican Business for $34M - Analyst Blog

Celgene's Revlimid Patent Families Do Not Appear To Meet Criteria For Protection

Yellen Sounds A Warning, Nasdaq Falls But Biotech Hangs On

See More MYL News...

MYL's Top Competitors

MYL $69.64 (-0.43%)
Current stock: MYL
JNJ $101.35 (-1.04%)
Current stock: JNJ
NVS $103.85 (-0.90%)
Current stock: NVS
RHHBY $36.83 (-0.94%)
Current stock: RHHBY